AP2007003982A0 - Use of androgens to reduce the likelihood of acquring or to treat skin aging - Google Patents

Use of androgens to reduce the likelihood of acquring or to treat skin aging

Info

Publication number
AP2007003982A0
AP2007003982A0 AP2007003982A AP2007003982A AP2007003982A0 AP 2007003982 A0 AP2007003982 A0 AP 2007003982A0 AP 2007003982 A AP2007003982 A AP 2007003982A AP 2007003982 A AP2007003982 A AP 2007003982A AP 2007003982 A0 AP2007003982 A0 AP 2007003982A0
Authority
AP
ARIPO
Prior art keywords
acquring
androgens
likelihood
reduce
skin aging
Prior art date
Application number
AP2007003982A
Other languages
English (en)
Inventor
Mohamed El-Alfy
Fernand Labire
Lamia Azzi
Original Assignee
Endorech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorech Inc filed Critical Endorech Inc
Publication of AP2007003982A0 publication Critical patent/AP2007003982A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AP2007003982A 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquring or to treat skin aging AP2007003982A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62411204P 2004-11-01 2004-11-01
PCT/CA2005/001652 WO2006047859A1 (en) 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquiring or to treat skin aging

Publications (1)

Publication Number Publication Date
AP2007003982A0 true AP2007003982A0 (en) 2007-06-30

Family

ID=36318842

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007003982A AP2007003982A0 (en) 2004-11-01 2005-10-31 Use of androgens to reduce the likelihood of acquring or to treat skin aging

Country Status (20)

Country Link
US (1) US20060178352A1 (ko)
EP (1) EP1807062A4 (ko)
JP (1) JP2008517952A (ko)
KR (1) KR20070073964A (ko)
CN (1) CN101094676A (ko)
AP (1) AP2007003982A0 (ko)
AU (1) AU2005301035A1 (ko)
BR (1) BRPI0517950A (ko)
CA (1) CA2585666A1 (ko)
EA (1) EA200700983A1 (ko)
GE (1) GEP20094833B (ko)
HR (1) HRP20070183A2 (ko)
IL (1) IL182844A0 (ko)
MA (1) MA29220B1 (ko)
MX (1) MX2007005098A (ko)
NO (1) NO20072642L (ko)
RS (1) RS20070185A (ko)
TN (1) TNSN07163A1 (ko)
WO (1) WO2006047859A1 (ko)
ZA (1) ZA200703531B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101106999B (zh) 2004-10-20 2017-06-09 恩多研究公司 单独的性甾体前体用于预防和治疗绝经后女性的阴道干燥和性功能障碍
JP4821852B2 (ja) 2006-06-01 2011-11-24 パナソニック株式会社 洗濯機用ブラシレスモータおよびそれを搭載した洗濯機
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
WO2015055179A1 (de) * 2013-10-15 2015-04-23 Chelac Holding Gmbh Steroid-carbonsäureester, zusammensetzungen, enthaltend steroid-carbonsäureester und verwendung dieser bei lokal topischer applikation für kosmetische oder dermatologische zwecke
EP3332787A4 (en) * 2015-09-30 2018-08-01 Fujifilm Corporation Transdermally absorbable composition
JP2022548314A (ja) * 2019-09-23 2022-11-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 妊娠を遷延させるためおよび月経または妊娠の合併症の処置の方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL88180C (ko) * 1953-08-26
SK286051B6 (sk) * 1993-01-19 2008-02-05 Endorecherche Inc. Použitie prekurzora pohlavného steroidu na prípravu liečiva na prevenciu alebo liečenie znížených alebo nevyrovnaných koncentrácií pohlavných steroidov
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
CN100377711C (zh) * 1998-06-11 2008-04-02 内部研究股份有限公司 雄-5-烯-3β,17β-二醇的药物组合物及其用途
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
IL157535A0 (en) * 2003-08-21 2004-03-28 Topimed Ltd Preparations for the prevention of skin atrophy

Also Published As

Publication number Publication date
MA29220B1 (fr) 2008-02-01
TNSN07163A1 (en) 2008-11-21
JP2008517952A (ja) 2008-05-29
US20060178352A1 (en) 2006-08-10
WO2006047859A1 (en) 2006-05-11
ZA200703531B (en) 2008-07-30
AU2005301035A1 (en) 2006-05-11
KR20070073964A (ko) 2007-07-10
EA200700983A1 (ru) 2008-04-28
HRP20070183A2 (en) 2007-08-31
CA2585666A1 (en) 2006-05-11
CN101094676A (zh) 2007-12-26
IL182844A0 (en) 2007-09-20
EP1807062A4 (en) 2009-06-03
EP1807062A1 (en) 2007-07-18
RS20070185A (en) 2008-09-29
MX2007005098A (es) 2008-01-16
NO20072642L (no) 2007-07-30
BRPI0517950A (pt) 2008-10-21
GEP20094833B (en) 2009-11-25

Similar Documents

Publication Publication Date Title
PL2689767T3 (pl) Kompozycje i sposoby ich stosowania do poprawy stanu i wyglądu skóry
EP1727530A4 (en) TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
EP1755661A4 (en) USE OF GELSOLINE FOR THE TREATMENT OF INFECTIONS
EP1755584A4 (en) TREATMENT OF MYOPIA
IL180078A (en) Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1663222A4 (en) METHODS RELATING TO THE TREATMENT OF GIANCES
EP1838714A4 (en) METHODS OF TREATING PAIN
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1765278A4 (en) SKIN AGING TREATMENT WITH PAEONIFLORIN
IL187405A0 (en) Methods and compositions for the treatment of pain
ZA200703531B (en) Use of androgens to reduce the likelihood of acquiring or to treat skin aging
HK1111141A1 (en) Compounds that stimulate glucose utilization and methods of use
GB2411834B (en) Composition for use in the treatment of dry skin conditions
EP1759020A4 (en) ACACS AS MODIFICATORS OF THE IGF PATH AND METHOD OF USE
GB0426196D0 (en) Methods of treatment
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
GB0701549D0 (en) Skin treatment
EP1846013A4 (en) TREATMENT OF SKIN DISEASES
EP1718329A4 (en) METHOD FOR THE TREATMENT OF SKIN DISEASES
ZA200607681B (en) Treatment of water
GB0408521D0 (en) Treatment of sepsis
GB0505203D0 (en) Skin composition treatment
ZA200710476B (en) Methods and compositions for the treatment of pain
GB2418357B (en) Improved personal washing or skin treatment aid